<
Advertisement

Seropositivity and Disability Predict Remission after IV Abatacept in Patients with RA

In a study of patients with rheumatoid arthritis (RA), researchers sought to identify baseline factors that are predictive of treatment remission after...

Greater VTE Incidence with Tofacitinib vs. TNFi for RA Patients with CV Risk Factors

An analysis of results from a randomized phase 3b/4 study demonstrated an increased risk of venous thromboembolic events with treatment of tofacitinib...

Work Productivity and Activity Loss in Patients with Newly Diagnosed RA

For individuals with recent-onset rheumatoid arthritis (RA), persistent disease activity was found to impair both work productivity and daily life activities, according...

Tumor Necrosis Factor Inhibition Increases Psoriasis Incidence in Children with JIA

A study presented at American College of Rheumatology (ACR) Convergence 2021 meeting found an increased risk of psoriasis after tumor necrosis factor...
Advertisement